APO Research
Talk to an analyst

APO RESEARCH · REPORT

Non-opioid Topical Pain Relief

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Non-opioid Topical Pain Relief Market Analysis and Forecast 2026-2032

22 December 2025197 pages

Choose your research edition.

Industry ResearchNon-opioid Topical Pain Relief Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-opioid Topical Pain Relief Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Non-opioid Topical Pain Relief Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-opioid Topical Pain Relief Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Non-opioid Topical Pain Relief Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Non-opioid Topical Pain Relief market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Non-opioid Topical Pain Relief is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Non-opioid Topical Pain Relief is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Non-opioid Topical Pain Relief is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Non-opioid Topical Pain Relief is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Non-opioid Topical Pain Relief include Teva Pharmaceutical, Sanofi, Johnson and Johnson, Mylan, Pfizer, GlaxoSmithKline, Topical BioMedics, Tibet Cheezheng Tibetan Medicine and Sun Pharmaceutical Industries, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Non-opioid Topical Pain Relief, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Non-opioid Topical Pain Relief, also provides the sales of main regions and countries. Of the upcoming market potential for Non-opioid Topical Pain Relief, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Non-opioid Topical Pain Relief sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Non-opioid Topical Pain Relief market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Non-opioid Topical Pain Relief sales, projected growth trends, production technology, application and end-user industry.

Non-opioid Topical Pain Relief Segment by Company

Teva Pharmaceutical

Sanofi

Johnson and Johnson

Mylan

Pfizer

GlaxoSmithKline

Topical BioMedics

Tibet Cheezheng Tibetan Medicine

Sun Pharmaceutical Industries

Reckitt Benckiser Group

Lingrui Pharmaceutical

Hisamitsu

China Resources Sanjiu Medical & Pharmaceutical

AdvaCare Pharma

Abacus Health Products

Non-opioid Topical Pain Relief Segment by Type

Prescription Pain Relief

Over-The-Counter Pain Relief

Non-opioid Topical Pain Relief Segment by Application

Clinic

Hospital

Pharmacy

Others

Non-opioid Topical Pain Relief Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-opioid Topical Pain Relief market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-opioid Topical Pain Relief and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-opioid Topical Pain Relief.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Non-opioid Topical Pain Relief in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Non-opioid Topical Pain Relief manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Non-opioid Topical Pain Relief sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Non-opioid Topical Pain Relief Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Prescription Pain Relief Major Manufacturers Table 3. Over-The-Counter Pain Relief Major Manufacturers Table 4. Global Non-opioid Topical Pain Relief Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Clinic Major Manufacturers Table 6. Hospital Major Manufacturers Table 7. Pharmacy Major Manufacturers Table 8. Others Major Manufacturers Table 9. Non-opioid Topical Pain Relief Industry Trends Table 10. Non-opioid Topical Pain Relief Industry Drivers Table 11. Non-opioid Topical Pain Relief Industry Opportunities and Challenges Table 12. Non-opioid Topical Pain Relief Industry Restraints Table 13. Global Non-opioid Topical Pain Relief Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Non-opioid Topical Pain Relief Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Non-opioid Topical Pain Relief Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Non-opioid Topical Pain Relief Revenue Market Share by Region (2021-2026) Table 17. Global Non-opioid Topical Pain Relief Revenue Market Share by Region (2027-2032) Table 18. Global Non-opioid Topical Pain Relief Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 19. Global Non-opioid Topical Pain Relief Sales by Region (2021-2026) & (k units) Table 20. Global Non-opioid Topical Pain Relief Sales by Region (2027-2032) & (k units) Table 21. Global Non-opioid Topical Pain Relief Sales Market Share by Region (2021-2026) Table 22. Global Non-opioid Topical Pain Relief Sales Market Share by Region (2027-2032) Table 23. Global Non-opioid Topical Pain Relief Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Non-opioid Topical Pain Relief Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Non-opioid Topical Pain Relief Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Non-opioid Topical Pain Relief Sales Market Share by Manufacturers (2021-2026) Table 27. Global Non-opioid Topical Pain Relief Sales Price (US$/unit) of Manufacturers (2021-2026) Table 28. Global Non-opioid Topical Pain Relief Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Non-opioid Topical Pain Relief Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Non-opioid Topical Pain Relief Manufacturers, Product Type & Application Table 31. Global Non-opioid Topical Pain Relief Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Non-opioid Topical Pain Relief by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Non-opioid Topical Pain Relief Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Non-opioid Topical Pain Relief Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Non-opioid Topical Pain Relief Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Non-opioid Topical Pain Relief Revenue Market Share by Type (2021-2026) Table 38. Global Non-opioid Topical Pain Relief Revenue Market Share by Type (2027-2032) Table 39. Global Non-opioid Topical Pain Relief Sales by Type 2021 VS 2025 VS 2032 (k units) Table 40. Global Non-opioid Topical Pain Relief Sales by Type (2021-2026) & (k units) Table 41. Global Non-opioid Topical Pain Relief Sales by Type (2027-2032) & (k units) Table 42. Global Non-opioid Topical Pain Relief Sales Market Share by Type (2021-2026) Table 43. Global Non-opioid Topical Pain Relief Sales Market Share by Type (2027-2032) Table 44. Global Non-opioid Topical Pain Relief Price by Type (2021-2026) & (US$/unit) Table 45. Global Non-opioid Topical Pain Relief Price by Type (2027-2032) & (US$/unit) Table 46. Global Non-opioid Topical Pain Relief Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Non-opioid Topical Pain Relief Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Non-opioid Topical Pain Relief Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Non-opioid Topical Pain Relief Revenue Market Share by Application (2021-2026) Table 50. Global Non-opioid Topical Pain Relief Revenue Market Share by Application (2027-2032) Table 51. Global Non-opioid Topical Pain Relief Sales by Application 2021 VS 2025 VS 2032 (k units) Table 52. Global Non-opioid Topical Pain Relief Sales by Application (2021-2026) & (k units) Table 53. Global Non-opioid Topical Pain Relief Sales by Application (2027-2032) & (k units) Table 54. Global Non-opioid Topical Pain Relief Sales Market Share by Application (2021-2026) Table 55. Global Non-opioid Topical Pain Relief Sales Market Share by Application (2027-2032) Table 56. Global Non-opioid Topical Pain Relief Price by Application (2021-2026) & (US$/unit) Table 57. Global Non-opioid Topical Pain Relief Price by Application (2027-2032) & (US$/unit) Table 58. Teva Pharmaceutical Company Information Table 59. Teva Pharmaceutical Business Overview Table 60. Teva Pharmaceutical Non-opioid Topical Pain Relief Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Teva Pharmaceutical Non-opioid Topical Pain Relief Product Portfolio Table 62. Teva Pharmaceutical Recent Development Table 63. Sanofi Company Information Table 64. Sanofi Business Overview Table 65. Sanofi Non-opioid Topical Pain Relief Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Sanofi Non-opioid Topical Pain Relief Product Portfolio Table 67. Sanofi Recent Development Table 68. Johnson and Johnson Company Information Table 69. Johnson and Johnson Business Overview Table 70. Johnson and Johnson Non-opioid Topical Pain Relief Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Johnson and Johnson Non-opioid Topical Pain Relief Product Portfolio Table 72. Johnson and Johnson Recent Development Table 73. Mylan Company Information Table 74. Mylan Business Overview Table 75. Mylan Non-opioid Topical Pain Relief Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Mylan Non-opioid Topical Pain Relief Product Portfolio Table 77. Mylan Recent Development Table 78. Pfizer Company Information Table 79. Pfizer Business Overview Table 80. Pfizer Non-opioid Topical Pain Relief Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Pfizer Non-opioid Topical Pain Relief Product Portfolio Table 82. Pfizer Recent Development Table 83. GlaxoSmithKline Company Information Table 84. GlaxoSmithKline Business Overview Table 85. GlaxoSmithKline Non-opioid Topical Pain Relief Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. GlaxoSmithKline Non-opioid Topical Pain Relief Product Portfolio Table 87. GlaxoSmithKline Recent Development Table 88. Topical BioMedics Company Information Table 89. Topical BioMedics Business Overview Table 90. Topical BioMedics Non-opioid Topical Pain Relief Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Topical BioMedics Non-opioid Topical Pain Relief Product Portfolio Table 92. Topical BioMedics Recent Development Table 93. Tibet Cheezheng Tibetan Medicine Company Information Table 94. Tibet Cheezheng Tibetan Medicine Business Overview Table 95. Tibet Cheezheng Tibetan Medicine Non-opioid Topical Pain Relief Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Tibet Cheezheng Tibetan Medicine Non-opioid Topical Pain Relief Product Portfolio Table 97. Tibet Cheezheng Tibetan Medicine Recent Development Table 98. Sun Pharmaceutical Industries Company Information Table 99. Sun Pharmaceutical Industries Business Overview Table 100. Sun Pharmaceutical Industries Non-opioid Topical Pain Relief Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Sun Pharmaceutical Industries Non-opioid Topical Pain Relief Product Portfolio Table 102. Sun Pharmaceutical Industries Recent Development Table 103. Reckitt Benckiser Group Company Information Table 104. Reckitt Benckiser Group Business Overview Table 105. Reckitt Benckiser Group Non-opioid Topical Pain Relief Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. Reckitt Benckiser Group Non-opioid Topical Pain Relief Product Portfolio Table 107. Reckitt Benckiser Group Recent Development Table 108. Lingrui Pharmaceutical Company Information Table 109. Lingrui Pharmaceutical Business Overview Table 110. Lingrui Pharmaceutical Non-opioid Topical Pain Relief Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. Lingrui Pharmaceutical Non-opioid Topical Pain Relief Product Portfolio Table 112. Lingrui Pharmaceutical Recent Development Table 113. Hisamitsu Company Information Table 114. Hisamitsu Business Overview Table 115. Hisamitsu Non-opioid Topical Pain Relief Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 116. Hisamitsu Non-opioid Topical Pain Relief Product Portfolio Table 117. Hisamitsu Recent Development Table 118. China Resources Sanjiu Medical & Pharmaceutical Company Information Table 119. China Resources Sanjiu Medical & Pharmaceutical Business Overview Table 120. China Resources Sanjiu Medical & Pharmaceutical Non-opioid Topical Pain Relief Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 121. China Resources Sanjiu Medical & Pharmaceutical Non-opioid Topical Pain Relief Product Portfolio Table 122. China Resources Sanjiu Medical & Pharmaceutical Recent Development Table 123. AdvaCare Pharma Company Information Table 124. AdvaCare Pharma Business Overview Table 125. AdvaCare Pharma Non-opioid Topical Pain Relief Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 126. AdvaCare Pharma Non-opioid Topical Pain Relief Product Portfolio Table 127. AdvaCare Pharma Recent Development Table 128. Abacus Health Products Company Information Table 129. Abacus Health Products Business Overview Table 130. Abacus Health Products Non-opioid Topical Pain Relief Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 131. Abacus Health Products Non-opioid Topical Pain Relief Product Portfolio Table 132. Abacus Health Products Recent Development Table 133. North America Non-opioid Topical Pain Relief Revenue by Type (2021-2026) & (US$ Million) Table 134. North America Non-opioid Topical Pain Relief Revenue by Type (2027-2032) & (US$ Million) Table 135. North America Non-opioid Topical Pain Relief Sales by Type (2021-2026) & (k units) Table 136. North America Non-opioid Topical Pain Relief Sales by Type (2027-2032) & (k units) Table 137. North America Non-opioid Topical Pain Relief Sales Price by Type (2021-2026) & (US$/unit) Table 138. North America Non-opioid Topical Pain Relief Sales Price by Type (2027-2032) & (US$/unit) Table 139. North America Non-opioid Topical Pain Relief Revenue by Application (2021-2026) & (US$ Million) Table 140. North America Non-opioid Topical Pain Relief Revenue by Application (2027-2032) & (US$ Million) Table 141. North America Non-opioid Topical Pain Relief Sales by Application (2021-2026) & (k units) Table 142. North America Non-opioid Topical Pain Relief Sales by Application (2027-2032) & (k units) Table 143. North America Non-opioid Topical Pain Relief Sales Price by Application (2021-2026) & (US$/unit) Table 144. North America Non-opioid Topical Pain Relief Sales Price by Application (2027-2032) & (US$/unit) Table 145. North America Non-opioid Topical Pain Relief Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 146. North America Non-opioid Topical Pain Relief Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 147. North America Non-opioid Topical Pain Relief Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 148. North America Non-opioid Topical Pain Relief Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 149. North America Non-opioid Topical Pain Relief Sales by Country (2021-2026) & (k units) Table 150. North America Non-opioid Topical Pain Relief Sales by Country (2027-2032) & (k units) Table 151. North America Non-opioid Topical Pain Relief Sales Price by Country (2021-2026) & (US$/unit) Table 152. North America Non-opioid Topical Pain Relief Sales Price by Country (2027-2032) & (US$/unit) Table 153. United States Non-opioid Topical Pain Relief Revenue (2021-2032) & (US$ Million) Table 154. Canada Non-opioid Topical Pain Relief Revenue (2021-2032) & (US$ Million) Table 155. Mexico Non-opioid Topical Pain Relief Revenue (2021-2032) & (US$ Million) Table 156. Europe Non-opioid Topical Pain Relief Revenue by Type (2021-2026) & (US$ Million) Table 157. Europe Non-opioid Topical Pain Relief Revenue by Type (2027-2032) & (US$ Million) Table 158. Europe Non-opioid Topical Pain Relief Sales by Type (2021-2026) & (k units) Table 159. Europe Non-opioid Topical Pain Relief Sales by Type (2027-2032) & (k units) Table 160. Europe Non-opioid Topical Pain Relief Sales Price by Type (2021-2026) & (US$/unit) Table 161. Europe Non-opioid Topical Pain Relief Sales Price by Type (2027-2032) & (US$/unit) Table 162. Europe Non-opioid Topical Pain Relief Revenue by Application (2021-2026) & (US$ Million) Table 163. Europe Non-opioid Topical Pain Relief Revenue by Application (2027-2032) & (US$ Million) Table 164. Europe Non-opioid Topical Pain Relief Sales by Application (2021-2026) & (k units) Table 165. Europe Non-opioid Topical Pain Relief Sales by Application (2027-2032) & (k units) Table 166. Europe Non-opioid Topical Pain Relief Sales Price by Application (2021-2026) & (US$/unit) Table 167. Europe Non-opioid Topical Pain Relief Sales Price by Application (2027-2032) & (US$/unit) Table 168. Europe Non-opioid Topical Pain Relief Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 169. Europe Non-opioid Topical Pain Relief Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 170. Europe Non-opioid Topical Pain Relief Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 171. Europe Non-opioid Topical Pain Relief Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 172. Europe Non-opioid Topical Pain Relief Sales by Country (2021-2026) & (k units) Table 173. Europe Non-opioid Topical Pain Relief Sales by Country (2027-2032) & (k units) Table 174. Europe Non-opioid Topical Pain Relief Sales Price by Country (2021-2026) & (US$/unit) Table 175. Europe Non-opioid Topical Pain Relief Sales Price by Country (2027-2032) & (US$/unit) Table 176. Germany Non-opioid Topical Pain Relief Revenue (2021-2032) & (US$ Million) Table 177. France Non-opioid Topical Pain Relief Revenue (2021-2032) & (US$ Million) Table 178. U.K. Non-opioid Topical Pain Relief Revenue (2021-2032) & (US$ Million) Table 179. Italy Non-opioid Topical Pain Relief Revenue (2021-2032) & (US$ Million) Table 180. Russia Non-opioid Topical Pain Relief Revenue (2021-2032) & (US$ Million) Table 181. Spain Non-opioid Topical Pain Relief Revenue (2021-2032) & (US$ Million) Table 182. Netherlands Non-opioid Topical Pain Relief Revenue (2021-2032) & (US$ Million) Table 183. Switzerland Non-opioid Topical Pain Relief Revenue (2021-2032) & (US$ Million) Table 184. Sweden Non-opioid Topical Pain Relief Revenue (2021-2032) & (US$ Million) Table 185. Poland Non-opioid Topical Pain Relief Revenue (2021-2032) & (US$ Million) Table 186. China Non-opioid Topical Pain Relief Revenue by Type (2021-2026) & (US$ Million) Table 187. China Non-opioid Topical Pain Relief Revenue by Type (2027-2032) & (US$ Million) Table 188. China Non-opioid Topical Pain Relief Sales by Type (2021-2026) & (k units) Table 189. China Non-opioid Topical Pain Relief Sales by Type (2027-2032) & (k units) Table 190. China Non-opioid Topical Pain Relief Sales Price by Type (2021-2026) & (US$/unit) Table 191. China Non-opioid Topical Pain Relief Sales Price by Type (2027-2032) & (US$/unit) Table 192. China Non-opioid Topical Pain Relief Revenue by Application (2021-2026) & (US$ Million) Table 193. China Non-opioid Topical Pain Relief Revenue by Application (2027-2032) & (US$ Million) Table 194. China Non-opioid Topical Pain Relief Sales by Application (2021-2026) & (k units) Table 195. China Non-opioid Topical Pain Relief Sales by Application (2027-2032) & (k units) Table 196. China Non-opioid Topical Pain Relief Sales Price by Application (2021-2026) & (US$/unit) Table 197. China Non-opioid Topical Pain Relief Sales Price by Application (2027-2032) & (US$/unit) Table 198. Asia Non-opioid Topical Pain Relief Revenue by Type (2021-2026) & (US$ Million) Table 199. Asia Non-opioid Topical Pain Relief Revenue by Type (2027-2032) & (US$ Million) Table 200. Asia Non-opioid Topical Pain Relief Sales by Type (2021-2026) & (k units) Table 201. Asia Non-opioid Topical Pain Relief Sales by Type (2027-2032) & (k units) Table 202. Asia Non-opioid Topical Pain Relief Sales Price by Type (2021-2026) & (US$/unit) Table 203. Asia Non-opioid Topical Pain Relief Sales Price by Type (2027-2032) & (US$/unit) Table 204. Asia Non-opioid Topical Pain Relief Revenue by Application (2021-2026) & (US$ Million) Table 205. Asia Non-opioid Topical Pain Relief Revenue by Application (2027-2032) & (US$ Million) Table 206. Asia Non-opioid Topical Pain Relief Sales by Application (2021-2026) & (k units) Table 207. Asia Non-opioid Topical Pain Relief Sales by Application (2027-2032) & (k units) Table 208. Asia Non-opioid Topical Pain Relief Sales Price by Application (2021-2026) & (US$/unit) Table 209. Asia Non-opioid Topical Pain Relief Sales Price by Application (2027-2032) & (US$/unit) Table 210. Asia Non-opioid Topical Pain Relief Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 211. Asia Non-opioid Topical Pain Relief Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 212. Asia Non-opioid Topical Pain Relief Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 213. Asia Non-opioid Topical Pain Relief Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 214. Asia Non-opioid Topical Pain Relief Sales by Country (2021-2026) & (k units) Table 215. Asia Non-opioid Topical Pain Relief Sales by Country (2027-2032) & (k units) Table 216. Asia Non-opioid Topical Pain Relief Sales Price by Country (2021-2026) & (US$/unit) Table 217. Asia Non-opioid Topical Pain Relief Sales Price by Country (2027-2032) & (US$/unit) Table 218. Japan Non-opioid Topical Pain Relief Revenue (2021-2032) & (US$ Million) Table 219. South Korea Non-opioid Topical Pain Relief Revenue (2021-2032) & (US$ Million) Table 220. India Non-opioid Topical Pain Relief Revenue (2021-2032) & (US$ Million) Table 221. Australia Non-opioid Topical Pain Relief Revenue (2021-2032) & (US$ Million) Table 222. Taiwan Non-opioid Topical Pain Relief Revenue (2021-2032) & (US$ Million) Table 223. Southeast Asia Non-opioid Topical Pain Relief Revenue (2021-2032) & (US$ Million) Table 224. SAMEA Non-opioid Topical Pain Relief Revenue by Type (2021-2026) & (US$ Million) Table 225. SAMEA Non-opioid Topical Pain Relief Revenue by Type (2027-2032) & (US$ Million) Table 226. SAMEA Non-opioid Topical Pain Relief Sales by Type (2021-2026) & (k units) Table 227. SAMEA Non-opioid Topical Pain Relief Sales by Type (2027-2032) & (k units) Table 228. SAMEA Non-opioid Topical Pain Relief Sales Price by Type (2021-2026) & (US$/unit) Table 229. SAMEA Non-opioid Topical Pain Relief Sales Price by Type (2027-2032) & (US$/unit) Table 230. SAMEA Non-opioid Topical Pain Relief Revenue by Application (2021-2026) & (US$ Million) Table 231. SAMEA Non-opioid Topical Pain Relief Revenue by Application (2027-2032) & (US$ Million) Table 232. SAMEA Non-opioid Topical Pain Relief Sales by Application (2021-2026) & (k units) Table 233. SAMEA Non-opioid Topical Pain Relief Sales by Application (2027-2032) & (k units) Table 234. SAMEA Non-opioid Topical Pain Relief Sales Price by Application (2021-2026) & (US$/unit) Table 235. SAMEA Non-opioid Topical Pain Relief Sales Price by Application (2027-2032) & (US$/unit) Table 236. SAMEA Non-opioid Topical Pain Relief Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 237. SAMEA Non-opioid Topical Pain Relief Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 238. SAMEA Non-opioid Topical Pain Relief Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 239. SAMEA Non-opioid Topical Pain Relief Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 240. SAMEA Non-opioid Topical Pain Relief Sales by Country (2021-2026) & (k units) Table 241. SAMEA Non-opioid Topical Pain Relief Sales by Country (2027-2032) & (k units) Table 242. SAMEA Non-opioid Topical Pain Relief Sales Price by Country (2021-2026) & (US$/unit) Table 243. SAMEA Non-opioid Topical Pain Relief Sales Price by Country (2027-2032) & (US$/unit) Table 244. Brazil Non-opioid Topical Pain Relief Revenue (2021-2032) & (US$ Million) Table 245. Argentina Non-opioid Topical Pain Relief Revenue (2021-2032) & (US$ Million) Table 246. Chile Non-opioid Topical Pain Relief Revenue (2021-2032) & (US$ Million) Table 247. Colombia Non-opioid Topical Pain Relief Revenue (2021-2032) & (US$ Million) Table 248. Peru Non-opioid Topical Pain Relief Revenue (2021-2032) & (US$ Million) Table 249. Saudi Arabia Non-opioid Topical Pain Relief Revenue (2021-2032) & (US$ Million) Table 250. Israel Non-opioid Topical Pain Relief Revenue (2021-2032) & (US$ Million) Table 251. UAE Non-opioid Topical Pain Relief Revenue (2021-2032) & (US$ Million) Table 252. Turkey Non-opioid Topical Pain Relief Revenue (2021-2032) & (US$ Million) Table 253. Iran Non-opioid Topical Pain Relief Revenue (2021-2032) & (US$ Million) Table 254. Egypt Non-opioid Topical Pain Relief Revenue (2021-2032) & (US$ Million) Table 255. Key Raw Materials Table 256. Raw Materials Key Suppliers Table 257. Non-opioid Topical Pain Relief Distributors List Table 258. Non-opioid Topical Pain Relief Customers List Table 259. Research Programs/Design for This Report Table 260. Authors List of This Report Table 261. Secondary Sources Table 262. Primary Sources List of Figures Figure 1. Non-opioid Topical Pain Relief Image Figure 2. Global Non-opioid Topical Pain Relief Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non-opioid Topical Pain Relief Market Size Share 2021 VS 2025 VS 2032 Figure 4. Prescription Pain Relief Image Figure 5. Over-The-Counter Pain Relief Image Figure 6. Global Non-opioid Topical Pain Relief Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Non-opioid Topical Pain Relief Market Size Share 2021 VS 2025 VS 2032 Figure 8. Clinic Image Figure 9. Hospital Image Figure 10. Pharmacy Image Figure 11. Others Image Figure 12. Global Non-opioid Topical Pain Relief Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Non-opioid Topical Pain Relief Revenue (2021-2032) & (US$ Million) Figure 14. Global Non-opioid Topical Pain Relief Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Non-opioid Topical Pain Relief Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Non-opioid Topical Pain Relief Revenue Market Share by Region (2021-2032) Figure 17. Global Non-opioid Topical Pain Relief Sales (2021-2032) & (k units) Figure 18. Global Non-opioid Topical Pain Relief Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 19. Global Non-opioid Topical Pain Relief Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Non-opioid Topical Pain Relief Sales YoY (2021-2032) & (k units) Figure 21. Europe Non-opioid Topical Pain Relief Sales YoY (2021-2032) & (k units) Figure 22. China Non-opioid Topical Pain Relief Sales YoY (2021-2032) & (k units) Figure 23. Asia (Excluding China) Non-opioid Topical Pain Relief Sales YoY (2021-2032) & (k units) Figure 24. South America, Middle East and Africa Non-opioid Topical Pain Relief Sales YoY (2021-2032) & (k units) Figure 25. Global Non-opioid Topical Pain Relief Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Non-opioid Topical Pain Relief Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Non-opioid Topical Pain Relief Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Non-opioid Topical Pain Relief Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Non-opioid Topical Pain Relief Revenue Market Share by Type (2021-2032) Figure 31. Global Non-opioid Topical Pain Relief Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 32. Global Non-opioid Topical Pain Relief Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Non-opioid Topical Pain Relief Sales Market Share by Type (2021-2032) Figure 34. Global Non-opioid Topical Pain Relief Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Non-opioid Topical Pain Relief Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Non-opioid Topical Pain Relief Revenue Market Share by Application (2021-2032) Figure 37. Global Non-opioid Topical Pain Relief Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 38. Global Non-opioid Topical Pain Relief Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Non-opioid Topical Pain Relief Sales Market Share by Application (2021-2032) Figure 40. North America Non-opioid Topical Pain Relief Revenue Share by Type (2021-2032) Figure 41. North America Non-opioid Topical Pain Relief Sales Share by Type (2021-2032) Figure 42. North America Non-opioid Topical Pain Relief Revenue Share by Application (2021-2032) Figure 43. North America Non-opioid Topical Pain Relief Sales Share by Application (2021-2032) Figure 44. North America Non-opioid Topical Pain Relief Revenue Share by Country (2021-2032) Figure 45. North America Non-opioid Topical Pain Relief Sales Share by Country (2021-2032) Figure 46. Europe Non-opioid Topical Pain Relief Revenue Share by Type (2021-2032) Figure 47. Europe Non-opioid Topical Pain Relief Sales Share by Type (2021-2032) Figure 48. Europe Non-opioid Topical Pain Relief Revenue Share by Application (2021-2032) Figure 49. Europe Non-opioid Topical Pain Relief Sales Share by Application (2021-2032) Figure 50. Europe Non-opioid Topical Pain Relief Revenue Share by Country (2021-2032) Figure 51. Europe Non-opioid Topical Pain Relief Sales Share by Country (2021-2032) Figure 52. China Non-opioid Topical Pain Relief Revenue Share by Type (2021-2032) Figure 53. China Non-opioid Topical Pain Relief Sales Share by Type (2021-2032) Figure 54. China Non-opioid Topical Pain Relief Revenue Share by Application (2021-2032) Figure 55. China Non-opioid Topical Pain Relief Sales Share by Application (2021-2032) Figure 56. Asia Non-opioid Topical Pain Relief Revenue Share by Type (2021-2032) Figure 57. Asia Non-opioid Topical Pain Relief Sales Share by Type (2021-2032) Figure 58. Asia Non-opioid Topical Pain Relief Revenue Share by Application (2021-2032) Figure 59. Asia Non-opioid Topical Pain Relief Sales Share by Application (2021-2032) Figure 60. Asia Non-opioid Topical Pain Relief Revenue Share by Country (2021-2032) Figure 61. Asia Non-opioid Topical Pain Relief Sales Share by Country (2021-2032) Figure 62. SAMEA Non-opioid Topical Pain Relief Revenue Share by Type (2021-2032) Figure 63. SAMEA Non-opioid Topical Pain Relief Sales Share by Type (2021-2032) Figure 64. SAMEA Non-opioid Topical Pain Relief Revenue Share by Application (2021-2032) Figure 65. SAMEA Non-opioid Topical Pain Relief Sales Share by Application (2021-2032) Figure 66. SAMEA Non-opioid Topical Pain Relief Revenue Share by Country (2021-2032) Figure 67. SAMEA Non-opioid Topical Pain Relief Sales Share by Country (2021-2032) Figure 68. Non-opioid Topical Pain Relief Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Non-opioid Topical Pain Relief Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Prescription Pain Relief
  • Over-The-Counter Pain Relief
Applications
  • Clinic
  • Hospital
  • Pharmacy
  • Others
Companies covered
  • Teva Pharmaceutical
  • Sanofi
  • Johnson and Johnson
  • Mylan
  • Pfizer
  • GlaxoSmithKline
  • Topical BioMedics
  • Tibet Cheezheng Tibetan Medicine
  • Sun Pharmaceutical Industries
  • Reckitt Benckiser Group
  • Lingrui Pharmaceutical
  • Hisamitsu
  • China Resources Sanjiu Medical & Pharmaceutical
  • AdvaCare Pharma
  • Abacus Health Products

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Non-opioid Topical Pain Relief Market by Type
  3. 1.2.1 Global Non-opioid Topical Pain Relief Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Prescription Pain Relief
  5. 1.2.3 Over-The-Counter Pain Relief
  6. 1.3 Non-opioid Topical Pain Relief Market by Application
  7. 1.3.1 Global Non-opioid Topical Pain Relief Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Clinic
  9. 1.3.3 Hospital
  10. 1.3.4 Pharmacy
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Non-opioid Topical Pain Relief Market Dynamics
  1. 2.1 Non-opioid Topical Pain Relief Industry Trends
  2. 2.2 Non-opioid Topical Pain Relief Industry Drivers
  3. 2.3 Non-opioid Topical Pain Relief Industry Opportunities and Challenges
  4. 2.4 Non-opioid Topical Pain Relief Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Non-opioid Topical Pain Relief Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Non-opioid Topical Pain Relief Revenue by Region
  3. 3.2.1 Global Non-opioid Topical Pain Relief Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Non-opioid Topical Pain Relief Revenue by Region (2021-2026)
  5. 3.2.3 Global Non-opioid Topical Pain Relief Revenue by Region (2027-2032)
  6. 3.2.4 Global Non-opioid Topical Pain Relief Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Non-opioid Topical Pain Relief Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Non-opioid Topical Pain Relief Sales by Region
  9. 3.4.1 Global Non-opioid Topical Pain Relief Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Non-opioid Topical Pain Relief Sales by Region (2021-2026)
  11. 3.4.3 Global Non-opioid Topical Pain Relief Sales by Region (2027-2032)
  12. 3.4.4 Global Non-opioid Topical Pain Relief Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Non-opioid Topical Pain Relief Revenue by Manufacturers
  2. 4.1.1 Global Non-opioid Topical Pain Relief Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Non-opioid Topical Pain Relief Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Non-opioid Topical Pain Relief Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Non-opioid Topical Pain Relief Sales by Manufacturers
  6. 4.2.1 Global Non-opioid Topical Pain Relief Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Non-opioid Topical Pain Relief Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Non-opioid Topical Pain Relief Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Non-opioid Topical Pain Relief Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Non-opioid Topical Pain Relief Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Non-opioid Topical Pain Relief Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Non-opioid Topical Pain Relief Manufacturers, Product Type & Application
  13. 4.7 Global Non-opioid Topical Pain Relief Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Non-opioid Topical Pain Relief Market CR5 and HHI
  16. 4.8.2 2025 Non-opioid Topical Pain Relief Tier 1, Tier 2, and Tier 3
5 Non-opioid Topical Pain Relief Market by Type
  1. 5.1 Global Non-opioid Topical Pain Relief Revenue by Type
  2. 5.1.1 Global Non-opioid Topical Pain Relief Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Non-opioid Topical Pain Relief Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Non-opioid Topical Pain Relief Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Non-opioid Topical Pain Relief Sales by Type
  6. 5.2.1 Global Non-opioid Topical Pain Relief Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Non-opioid Topical Pain Relief Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Non-opioid Topical Pain Relief Sales Market Share by Type (2021-2032)
  9. 5.3 Global Non-opioid Topical Pain Relief Price by Type
6 Non-opioid Topical Pain Relief Market by Application
  1. 6.1 Global Non-opioid Topical Pain Relief Revenue by Application
  2. 6.1.1 Global Non-opioid Topical Pain Relief Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Non-opioid Topical Pain Relief Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Non-opioid Topical Pain Relief Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Non-opioid Topical Pain Relief Sales by Application
  6. 6.2.1 Global Non-opioid Topical Pain Relief Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Non-opioid Topical Pain Relief Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Non-opioid Topical Pain Relief Sales Market Share by Application (2021-2032)
  9. 6.3 Global Non-opioid Topical Pain Relief Price by Application
7 Company Profiles
  1. 7.1 Teva Pharmaceutical
  2. 7.1.1 Teva Pharmaceutical Company Information
  3. 7.1.2 Teva Pharmaceutical Business Overview
  4. 7.1.3 Teva Pharmaceutical Non-opioid Topical Pain Relief Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Teva Pharmaceutical Non-opioid Topical Pain Relief Product Portfolio
  6. 7.1.5 Teva Pharmaceutical Recent Developments
  7. 7.2 Sanofi
  8. 7.2.1 Sanofi Company Information
  9. 7.2.2 Sanofi Business Overview
  10. 7.2.3 Sanofi Non-opioid Topical Pain Relief Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sanofi Non-opioid Topical Pain Relief Product Portfolio
  12. 7.2.5 Sanofi Recent Developments
  13. 7.3 Johnson and Johnson
  14. 7.3.1 Johnson and Johnson Company Information
  15. 7.3.2 Johnson and Johnson Business Overview
  16. 7.3.3 Johnson and Johnson Non-opioid Topical Pain Relief Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Johnson and Johnson Non-opioid Topical Pain Relief Product Portfolio
  18. 7.3.5 Johnson and Johnson Recent Developments
  19. 7.4 Mylan
  20. 7.4.1 Mylan Company Information
  21. 7.4.2 Mylan Business Overview
  22. 7.4.3 Mylan Non-opioid Topical Pain Relief Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Mylan Non-opioid Topical Pain Relief Product Portfolio
  24. 7.4.5 Mylan Recent Developments
  25. 7.5 Pfizer
  26. 7.5.1 Pfizer Company Information
  27. 7.5.2 Pfizer Business Overview
  28. 7.5.3 Pfizer Non-opioid Topical Pain Relief Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Pfizer Non-opioid Topical Pain Relief Product Portfolio
  30. 7.5.5 Pfizer Recent Developments
  31. 7.6 GlaxoSmithKline
  32. 7.6.1 GlaxoSmithKline Company Information
  33. 7.6.2 GlaxoSmithKline Business Overview
  34. 7.6.3 GlaxoSmithKline Non-opioid Topical Pain Relief Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 GlaxoSmithKline Non-opioid Topical Pain Relief Product Portfolio
  36. 7.6.5 GlaxoSmithKline Recent Developments
  37. 7.7 Topical BioMedics
  38. 7.7.1 Topical BioMedics Company Information
  39. 7.7.2 Topical BioMedics Business Overview
  40. 7.7.3 Topical BioMedics Non-opioid Topical Pain Relief Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Topical BioMedics Non-opioid Topical Pain Relief Product Portfolio
  42. 7.7.5 Topical BioMedics Recent Developments
  43. 7.8 Tibet Cheezheng Tibetan Medicine
  44. 7.8.1 Tibet Cheezheng Tibetan Medicine Company Information
  45. 7.8.2 Tibet Cheezheng Tibetan Medicine Business Overview
  46. 7.8.3 Tibet Cheezheng Tibetan Medicine Non-opioid Topical Pain Relief Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Tibet Cheezheng Tibetan Medicine Non-opioid Topical Pain Relief Product Portfolio
  48. 7.8.5 Tibet Cheezheng Tibetan Medicine Recent Developments
  49. 7.9 Sun Pharmaceutical Industries
  50. 7.9.1 Sun Pharmaceutical Industries Company Information
  51. 7.9.2 Sun Pharmaceutical Industries Business Overview
  52. 7.9.3 Sun Pharmaceutical Industries Non-opioid Topical Pain Relief Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Sun Pharmaceutical Industries Non-opioid Topical Pain Relief Product Portfolio
  54. 7.9.5 Sun Pharmaceutical Industries Recent Developments
  55. 7.10 Reckitt Benckiser Group
  56. 7.10.1 Reckitt Benckiser Group Company Information
  57. 7.10.2 Reckitt Benckiser Group Business Overview
  58. 7.10.3 Reckitt Benckiser Group Non-opioid Topical Pain Relief Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Reckitt Benckiser Group Non-opioid Topical Pain Relief Product Portfolio
  60. 7.10.5 Reckitt Benckiser Group Recent Developments
  61. 7.11 Lingrui Pharmaceutical
  62. 7.11.1 Lingrui Pharmaceutical Company Information
  63. 7.11.2 Lingrui Pharmaceutical Business Overview
  64. 7.11.3 Lingrui Pharmaceutical Non-opioid Topical Pain Relief Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Lingrui Pharmaceutical Non-opioid Topical Pain Relief Product Portfolio
  66. 7.11.5 Lingrui Pharmaceutical Recent Developments
  67. 7.12 Hisamitsu
  68. 7.12.1 Hisamitsu Company Information
  69. 7.12.2 Hisamitsu Business Overview
  70. 7.12.3 Hisamitsu Non-opioid Topical Pain Relief Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Hisamitsu Non-opioid Topical Pain Relief Product Portfolio
  72. 7.12.5 Hisamitsu Recent Developments
  73. 7.13 China Resources Sanjiu Medical & Pharmaceutical
  74. 7.13.1 China Resources Sanjiu Medical & Pharmaceutical Company Information
  75. 7.13.2 China Resources Sanjiu Medical & Pharmaceutical Business Overview
  76. 7.13.3 China Resources Sanjiu Medical & Pharmaceutical Non-opioid Topical Pain Relief Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 China Resources Sanjiu Medical & Pharmaceutical Non-opioid Topical Pain Relief Product Portfolio
  78. 7.13.5 China Resources Sanjiu Medical & Pharmaceutical Recent Developments
  79. 7.14 AdvaCare Pharma
  80. 7.14.1 AdvaCare Pharma Company Information
  81. 7.14.2 AdvaCare Pharma Business Overview
  82. 7.14.3 AdvaCare Pharma Non-opioid Topical Pain Relief Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 AdvaCare Pharma Non-opioid Topical Pain Relief Product Portfolio
  84. 7.14.5 AdvaCare Pharma Recent Developments
  85. 7.15 Abacus Health Products
  86. 7.15.1 Abacus Health Products Company Information
  87. 7.15.2 Abacus Health Products Business Overview
  88. 7.15.3 Abacus Health Products Non-opioid Topical Pain Relief Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Abacus Health Products Non-opioid Topical Pain Relief Product Portfolio
  90. 7.15.5 Abacus Health Products Recent Developments
8 North America
  1. 8.1 North America Non-opioid Topical Pain Relief Market Size by Type
  2. 8.1.1 North America Non-opioid Topical Pain Relief Revenue by Type (2021-2032)
  3. 8.1.2 North America Non-opioid Topical Pain Relief Sales by Type (2021-2032)
  4. 8.1.3 North America Non-opioid Topical Pain Relief Price by Type (2021-2032)
  5. 8.2 North America Non-opioid Topical Pain Relief Market Size by Application
  6. 8.2.1 North America Non-opioid Topical Pain Relief Revenue by Application (2021-2032)
  7. 8.2.2 North America Non-opioid Topical Pain Relief Sales by Application (2021-2032)
  8. 8.2.3 North America Non-opioid Topical Pain Relief Price by Application (2021-2032)
  9. 8.3 North America Non-opioid Topical Pain Relief Market Size by Country
  10. 8.3.1 North America Non-opioid Topical Pain Relief Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Non-opioid Topical Pain Relief Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Non-opioid Topical Pain Relief Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Non-opioid Topical Pain Relief Market Size by Type
  2. 9.1.1 Europe Non-opioid Topical Pain Relief Revenue by Type (2021-2032)
  3. 9.1.2 Europe Non-opioid Topical Pain Relief Sales by Type (2021-2032)
  4. 9.1.3 Europe Non-opioid Topical Pain Relief Price by Type (2021-2032)
  5. 9.2 Europe Non-opioid Topical Pain Relief Market Size by Application
  6. 9.2.1 Europe Non-opioid Topical Pain Relief Revenue by Application (2021-2032)
  7. 9.2.2 Europe Non-opioid Topical Pain Relief Sales by Application (2021-2032)
  8. 9.2.3 Europe Non-opioid Topical Pain Relief Price by Application (2021-2032)
  9. 9.3 Europe Non-opioid Topical Pain Relief Market Size by Country
  10. 9.3.1 Europe Non-opioid Topical Pain Relief Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Non-opioid Topical Pain Relief Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Non-opioid Topical Pain Relief Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Non-opioid Topical Pain Relief Market Size by Type
  2. 10.1.1 China Non-opioid Topical Pain Relief Revenue by Type (2021-2032)
  3. 10.1.2 China Non-opioid Topical Pain Relief Sales by Type (2021-2032)
  4. 10.1.3 China Non-opioid Topical Pain Relief Price by Type (2021-2032)
  5. 10.2 China Non-opioid Topical Pain Relief Market Size by Application
  6. 10.2.1 China Non-opioid Topical Pain Relief Revenue by Application (2021-2032)
  7. 10.2.2 China Non-opioid Topical Pain Relief Sales by Application (2021-2032)
  8. 10.2.3 China Non-opioid Topical Pain Relief Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Non-opioid Topical Pain Relief Market Size by Type
  2. 11.1.1 Asia Non-opioid Topical Pain Relief Revenue by Type (2021-2032)
  3. 11.1.2 Asia Non-opioid Topical Pain Relief Sales by Type (2021-2032)
  4. 11.1.3 Asia Non-opioid Topical Pain Relief Price by Type (2021-2032)
  5. 11.2 Asia Non-opioid Topical Pain Relief Market Size by Application
  6. 11.2.1 Asia Non-opioid Topical Pain Relief Revenue by Application (2021-2032)
  7. 11.2.2 Asia Non-opioid Topical Pain Relief Sales by Application (2021-2032)
  8. 11.2.3 Asia Non-opioid Topical Pain Relief Price by Application (2021-2032)
  9. 11.3 Asia Non-opioid Topical Pain Relief Market Size by Country
  10. 11.3.1 Asia Non-opioid Topical Pain Relief Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Non-opioid Topical Pain Relief Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Non-opioid Topical Pain Relief Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Non-opioid Topical Pain Relief Market Size by Type
  2. 12.1.1 SAMEA Non-opioid Topical Pain Relief Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Non-opioid Topical Pain Relief Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Non-opioid Topical Pain Relief Price by Type (2021-2032)
  5. 12.2 SAMEA Non-opioid Topical Pain Relief Market Size by Application
  6. 12.2.1 SAMEA Non-opioid Topical Pain Relief Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Non-opioid Topical Pain Relief Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Non-opioid Topical Pain Relief Price by Application (2021-2032)
  9. 12.3 SAMEA Non-opioid Topical Pain Relief Market Size by Country
  10. 12.3.1 SAMEA Non-opioid Topical Pain Relief Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Non-opioid Topical Pain Relief Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Non-opioid Topical Pain Relief Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Non-opioid Topical Pain Relief Value Chain Analysis
  2. 13.1.1 Non-opioid Topical Pain Relief Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Non-opioid Topical Pain Relief Production Mode & Process
  6. 13.2 Non-opioid Topical Pain Relief Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Non-opioid Topical Pain Relief Distributors
  9. 13.2.3 Non-opioid Topical Pain Relief Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst